The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model
Open accessAbstract
An antagonist of human monocyte chemoattractant protein (MCP)-1, which consists of MCP-1(9-76), had previously been characterized and shown to inhibit MCP-1 activity in vitro. To test the hypothesis that, by inhibiting endogenous MCP-1, the antagonist has antiinflammatory activity in vivo, we examined its effect in the MRL-lpr mouse model of arthritis. This strain spontaneously develops a chronic inflammatory arthritis that is similar to human rheumatoid arthritis. Daily injection of the antagonist, MCP-1(9-76), prevented the onset of arthritis as monitored by measuring joint swelling and by histopathological evaluation of the joints. In contrast, controls treated with native MCP-1 had enhanced arthritis symptoms, indicating that the inhibitory effect is specific to the antagonist. In experiments where the antagonist was given only after the disease had already developed, there was a marked reduction in symptoms and histopathology, although individuals varied in the magnitude of the response. The mechanism of inhibition of disease is not known, although the results suggest that it could be more complex than the competitive inhibition of ligand binding that is observed in vitro. The demonstration of the beneficial effects of an MCP-1 antagonist in arthritis suggests that chemokine receptor antagonists could have therapeutic application in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,226
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.
Carr, M. W., Roth, S. J., Luther, E., Rose, S. S., & Springer, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3652 · Cited by 1,198
Essential involvement of interleukin-8 (IL-8) in acute inflammation
Harada, A., Sekido, N., Akahoshi, T., Wada, T., Mukaida, N., & Matsushima, K. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.5.559 · Cited by 1,041
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
Koch, A. E., Kunkel, S. L., Harlow, L. A., Johnson, B., Evanoff, H. L., Haines, G. K., Burdick, M. D., Pope, R. M., & Strieter, R. M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115950 · Cited by 668
Jiang, Y., Beller, D. I., Frendl, G., & Graves, D. T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2423 · Cited by 501
Kitaura, M., Nakajima, T., Imai, T., Harada, S., Combadiere, C., Tiffany, H. L., Murphy, P. M., & Yoshie, O. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7725 · Cited by 408
Van Damme, J., Proost, P., Lenaerts, J. P., & Opdenakker, G. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.59 · Cited by 371
Structure-activity relationships of chemokines
Clark-Lewis, I., Kim, K.-S., Rajarathnam, K., Gong, J.-H., Dewald, B., Moser, B., Baggiolini, M., & Sykes, B. D. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.703 · Cited by 361
Self-citationA spontaneous rheumatoid arthritis-like disease in MRL/l mice.
Hang, L., Theofilopoulos, A. N., & Dixon, F. J. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1690 · Cited by 304
Cited by
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Immune cell migration in inflammation: present and future therapeutic targets
Luster, A. D., Alon, R., & von Andrian, U. H. (2005) · Nature Immunology · doi:10.1038/ni1275 · Cited by 1,313
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,041
Chemokine receptors: multifaceted therapeutic targets
Proudfoot, A. E. I. (2002) · Nature Reviews Immunology · doi:10.1038/nri722 · Cited by 752
Kuziel, W. A., Morgan, S. J., Dawson, T. C., Griffin, S., Smithies, O., Ley, K., & Maeda, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12053 · Cited by 709
Chemokines in pathology and medicine
Baggiolini, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00867.x · Cited by 677
Structure, Function, and Inhibition of Chemokines
Fernandez, E. J., & Lolis, E. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091901.115838 · Cited by 609
Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation
Viola, A., & Luster, A. D. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.121806.154841 · Cited by 583
Conant, K., Garzino-Demo, A., Nath, A., McArthur, J. C., Halliday, W., Power, C., Gallo, R. C., & Major, E. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3117 · Cited by 577
Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice
Mack, M., Cihak, J., Simonis, C., Luckow, B., Proudfoot, A. E. I., Plachý, J., Brühl, H., Frink, M., Anders, H.-J., Vielhauer, V., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4697 · Cited by 467
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases
Conductier, G., Blondeau, N., Guyon, A., Nahon, J.-L., & Rovère, C. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.010 · Cited by 404
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
Panee, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.06.018 · Cited by 402
G protein βγ subunits: Central mediators of G protein-coupled receptor signaling
Smrcka, A. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8006-5 · Cited by 365
Nakamachi, Y., Kawano, S., Takenokuchi, M., Nishimura, K., Sakai, Y., Chin, T., Saura, R., Kurosaka, M., & Kumagai, S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24475 · Cited by 332
Tesch, G. H., Maifert, S., Schwarting, A., Rollins, B. J., & Kelley, V. R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1813 · Cited by 303
T cell migration in rheumatoid arthritis
Mellado, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00384 · Cited by 291
White, G. E., Iqbal, A. J., & Greaves, D. R. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005074 · Cited by 289
Katschke, K. J., Rottman, J. B., Ruth, J. H., Qin, S., Wu, L., LaRosa, G., Ponath, P., Park, C. C., Pope, R. M., & Koch, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1022::aid-anr181>3.0.co;2-n · Cited by 286
The central and multiple roles of B cells in lupus pathogenesis
Chan, O. T. M., Madaio, M. R., Shlomchik, M. J., Chan, O. I. M., Madaio, M. P., & Shlomchik, M. J. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01310.x · Cited by 281
Weber, K. S. C., Nelson, P. J., Gröne, H.-J., & Weber, C. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2085 · Cited by 279
Nowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Huo, Y., Weber, C., Forlow, S. B., Sperandio, M., Thatte, J., Mack, M., Jung, S., Littman, D. R., & Ley, K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12877 · Cited by 266
Haringman, J. J., Gerlag, D. M., Smeets, T. J. M., Baeten, D., van den Bosch, F., Bresnihan, B., Breedveld, F. C., Dinant, H. J., Legay, F., Gram, H., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21975 · Cited by 258
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., Xue, Y. Y., Berlin, A., Ross, D. J., Kunkel, S. L., Charo, I. F., & Strieter, R. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12214 · Cited by 255
Kyriakides, T. R., Foster, M. J., Keeney, G. E., Tsai, A., Giachelli, C. M., Clark-Lewis, I., Rollins, B. J., & Bornstein, P. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63265-8 · Cited by 226
Self-citationCCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells
Kara, E. E., McKenzie, D. R., Bastow, C. R., Gregor, C. E., Fenix, K. A., Ogunniyi, A. D., Paton, J. C., Mack, M., Pombal, D. R., Seillet, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9644 · Cited by 136
Borghi, M. O., Panzeri, P., Shattock, R., Sozzani, S., Dobrina, A., & Meroni, P. L. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01186.x · Cited by 21
Metadata
- Authors
- Gong, J.-H., Ratkay, L. G., Waterfield, J. D., & Clark-Lewis, I.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-07-07
- Volume
- 186
- Issue
- 1
- Pages
- 131-137
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2153748057
- Cited by
- 375
- References
- 25
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.